{
    "clinical_study": {
        "@rank": "18332", 
        "arm_group": [
            {
                "arm_group_label": "sublingual", 
                "arm_group_type": "Placebo Comparator", 
                "description": "400 microgram m\u0131soprostol will be administered subl\u0131ngually before elective caesarean"
            }, 
            {
                "arm_group_label": "rectal", 
                "arm_group_type": "Placebo Comparator", 
                "description": "rectal 600 mgr misoprostol will be administered"
            }, 
            {
                "arm_group_label": "synpitan", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesis in this study is that administration of rectal and sublingual\n      misoprostol decreases intrapartum and postpartum haemorrhage."
        }, 
        "brief_title": "The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a Randomized Controlled Trial", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "\u0131ntrapartum Haemorrhage", 
            "Postpartum Haemorrhage"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Postpartum Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. live and singleton pregnancy\n\n          2. Elective caesarean\n\n          3. Gestational week greater than 37 weeks\n\n          4. patient between 18-44 year old\n\n        Exclusion Criteria:\n\n          1. -multiple pregnancy\n\n          2. Preeclampsia\n\n          3. Gestational diabetes\n\n          4. Macrosomia\n\n          5. Oligohidraamn\u0131os\n\n          6. Polihidraamn\u0131os\n\n          7. Myoma\n\n          8. Morbid obesity\n\n          9. Coagulat\u0131on defect (such as HELLP syndrome)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "44 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "618", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01931410", 
            "org_study_id": "A\u015f\u0131c\u0131o\u011flu-05"
        }, 
        "intervention": {
            "arm_group_label": [
                "sublingual", 
                "rectal"
            ], 
            "intervention_name": "Misoprostol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Misoprostol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 24, 2014", 
        "number_of_arms": "3", 
        "overall_official": {
            "affiliation": "T.C.S.B. Kanuni Sultan S\u00fcleyman Research Hospital", 
            "last_name": "Berhan A\u015eICIO\u011eLU, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Postpartum Haemorrhage", 
            "safety_issue": "Yes", 
            "time_frame": "postpartum 24 hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01931410"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Istanbul Bakirkoy Maternity and Children Diseases Hospital", 
            "investigator_full_name": "Osman A\u015f\u0131c\u0131o\u011flu", 
            "investigator_title": "M.D. Obstetric and Gynecology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Istanbul Bakirkoy Maternity and Children Diseases Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Istanbul Bakirkoy Maternity and Children Diseases Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}